Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2022 ∙ Cortés-Sarabia, K. Gutiérrez-Torres, M. Mendoza-Renteria, E. M. Leyva-Vázquez, M. A. Vences-Velázquez, A. Hernández-Sotelo, D. Beltrán-Anaya, F. O. Del Moral-Hernández, O. Illades-Aguiar, B.

Variation in the Humoral Immune Response Induced by the Administration of the BNT162b2 Pfizer/BioNTech Vaccine: A Systematic Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Martinez-Reviejo, R. Tejada, S. Adebanjo, G. A. R. Chello, C. Machado, M. C. Parisella, F. R. Campins, M. Tammaro, A. Rello, J.

Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Alhendyani, F. Jolly, K. Jones, L. L.

Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis

  • Healthcare workers
  • Influenza
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Nanishi, E. Levy, O. Ozonoff, A.

Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Gao, H. Lau, E. H. Y. Cowling, B. J.

Waning Immunity after Receipt of Pertussis, Diphtheria, Tetanus, and Polio-Related Vaccines: A Systematic Review and Meta-analysis

  • All age groups
  • Pertussis
  • Diphtheria
  • Tetanus
  • Poliomyelitis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kitamura, N. Bahkali, K. Chem, E. D. Quilty, B. J. Edwards, T. Toizumi, M. Yoshida, L. M.

Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis

  • All age groups
  • Diphtheria
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Moderate
2022 ∙ Paybast, S. Emami, A. Baghalha, F. Naser Moghadasi, A.

Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Romate, J. Rajkumar, E. Gopi, A. Abraham, J. Rages, J. Lakshmi, R. Jesline, J. Bhogle, S.

What Contributes to COVID-19 Vaccine Hesitancy? A Systematic Review of the Psychological Factors Associated with COVID-19 Vaccine Hesitancy

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Mitchell, H. Lim, R. Gill, P. K. Dhanoa, J. Dubé, È Bettinger, J. A.

What do adolescents think about vaccines? Systematic review of qualitative studies

  • Adolescents
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ MacMahon, A. Nayar, S. K. Srikumaran, U.

What Do We Know About Shoulder Injury Related to Vaccine Administration? An Updated Systematic Review

  • Adolescents
  • Adults
  • Older adults
  • Administration
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...